Literature DB >> 24180387

Tetrahydrobiopterin regulation of eNOS redox function.

Dan-Dan Chen, Lu-Yuan Chen, Ji-Biao Xie, Chang Shu, Tianlun Yang, Shenghua Zhou, Hong Yuan, Alex F Chen1.   

Abstract

Tetrahydrobiopterin (BH4) is an essential cofactor of nitric oxide synthase (NOS). In the cardiovascular system, endothelial NOS (eNOS) has a major role in maintaining vascular tone and endothelial function, as well as in mediating many other vascular protective properties. Evidence from humans and animals have demonstrated that decreased BH4 bioavailability, with subsequent uncoupling of eNOS, has significant effects on the pathogenesis of endothelial dysfunction, which is a hallmark of vascular injury in cardiovascular disorders, including hypertension, hyperlipidemia, and diabetes. In this review, we discuss the synthesis of BH4, its molecular mechanisms regulating eNOS coupling, the pathophysiologic roles of decreased BH4 bioavailability in cardiovascular diseases, and the potential therapeutic application of BH4 in clinics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24180387     DOI: 10.2174/13816128113196660747

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  10 in total

Review 1.  Sex, Oxidative Stress, and Hypertension: Insights From Animal Models.

Authors:  Jane F Reckelhoff; Damian G Romero; Licy L Yanes Cardozo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

Review 2.  Role of folic acid in nitric oxide bioavailability and vascular endothelial function.

Authors:  Anna E Stanhewicz; W Larry Kenney
Journal:  Nutr Rev       Date:  2017-01       Impact factor: 7.110

3.  Diminished nitric oxide generation from neutrophils suppresses platelet activation in chronic renal failure.

Authors:  Daniele C Abrantes; Tatiana M C Brunini; Cristiane Matsuura; Wanda Vianna Mury; Carolina R Corrêa; Sérgio F Santos; Monique B O Ormonde do Carmo; Antônio Cláudio Mendes-Ribeiro
Journal:  Mol Cell Biochem       Date:  2014-12-19       Impact factor: 3.396

Review 4.  The roles of FGF21 in atherosclerosis pathogenesis.

Authors:  Farzane Shanebandpour Tabari; Ansar Karimian; Hadi Parsian; Vahid Rameshknia; Ata Mahmoodpour; Maryam Majidinia; Mahmood Maniati; Bahman Yousefi
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

5.  Loss of cAMP-dependent stimulation of isolated cilia motility by alcohol exposure is oxidant-dependent.

Authors:  Michael E Price; Carresse L Gerald; Jacqueline A Pavlik; Sarah L Schlichte; Matthew C Zimmerman; Jane M DeVasure; Todd A Wyatt; Joseph H Sisson
Journal:  Alcohol       Date:  2018-10-03       Impact factor: 2.405

Review 6.  Therapeutic Potential of Polyphenols-Loaded Polymeric Nanoparticles in Cardiovascular System.

Authors:  Olga Pechanova; Ezgi Dayar; Martina Cebova
Journal:  Molecules       Date:  2020-07-22       Impact factor: 4.411

7.  PPARD May Play a Protective Role for Major Depressive Disorder.

Authors:  Tao Yang; Juhua Li; Liyuan Li; Xuehua Huang; Jiajun Xu; Xia Huang; Lijuan Huang; Kamil Can Kural
Journal:  PPAR Res       Date:  2021-04-21       Impact factor: 4.964

8.  Inflammation of the Human Dental Pulp Induces Phosphorylation of eNOS at Thr495 in Blood Vessels.

Authors:  Özlem Erdek; Wilhelm Bloch; Svenja Rink-Notzon; Hubert C Roggendorf; Senem Uzun; Britta Meul; Manuel Koch; Jörg Neugebauer; James Deschner; Yüksel Korkmaz
Journal:  Biomedicines       Date:  2022-07-03

9.  Reply: Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.

Authors:  Niccolo E Mencacci; Alan M Pittman; Ioannis U Isaias; John Hardy; Stephan Klebe; Kailash P Bhatia; Nicholas W Wood
Journal:  Brain       Date:  2014-11-14       Impact factor: 13.501

Review 10.  Aquaporin Membrane Channels in Oxidative Stress, Cell Signaling, and Aging: Recent Advances and Research Trends.

Authors:  Grazia Tamma; Giovanna Valenti; Elena Grossini; Sandra Donnini; Angela Marino; Raul A Marinelli; Giuseppe Calamita
Journal:  Oxid Med Cell Longev       Date:  2018-03-27       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.